In this update, we consider the impact on parallel trade following the introduction of additional safety features for medicine packaging under the EU Falsified Medicines Directive, plus we discuss the requirement for establishment in the UK following Brexit. In the latest entry to our Life Sciences Legal A to Z, we explain why it's advisable for parties to enter into a written contract before embarking on a project.
In case you missed it, the sixth and seventh episodes of our podcast series "Meeting Room 7" are out now, in which we discuss the practical aspects of disputes that might arise from patent and know how licensing agreements and what needs to be considered when negotiating warranties, indemnities and liability provisions.
A link to the web version of this email update is available here. If you would like to receive these updates via email, please subscribe.
Charlotte Tillett
Gustaf Duhs